Sun Pharma, Hetero recall drugs in US
Sun Pharma is recalling a generic drug indicated to raise blood pressure in adults while Hetero Labs is recalling a drug used to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Hetero
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
Movfor phase-III trials show positive results: Hetero
Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the…
Manufacturing capacity of Remdesivir ramped up to around 1.19 cr crore vials a month: Govt
With the accelerated approval of 38 additional manufacturing sites, the number of approved manufacturing sites of remdesivir in…
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun…
India to make 300 million Sputnik V vaccines
India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year, a Russian official was quoted as…
Sputnik V vaccine efficacy is 91.4 per cent: RDIF, Gamaleya Center
Based on the data obtained at the third control point, the Gamaleya Center will create a report that will be used to submit for…
RDIF and Hetero agree to produce over 100 million doses of Sputnik V vaccine in India
The Gamaleya Center and RDIF announced on November 24 positive results obtained during the second interim data analysis of the…
HEAL Foundation organises Pharma Excellence Awards 2020
Pharma companies awarded for their exemplary work during COVID-19 crisis
Remdesivir treatment gains popularity in India, black marketing and price cuts to continue:…
According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.